Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 15/2021

Content (14 Articles)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

  • Open Access
  • Leading Article

Martin Hoenigl, Rosanne Sprute, Matthias Egger, Amir Arastehfar, Oliver A. Cornely, Robert Krause, Cornelia Lass-Flörl, Juergen Prattes, Andrej Spec, George R. Thompson III, Nathan Wiederhold, Jeffrey D. Jenks

Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders

  • Review Article

Racheal Grace Akwii, Constantinos M. Mikelis

Bimekizumab for the Treatment of Psoriasis

Egídio Freitas, Andrew Blauvelt, Tiago Torres

REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

Christian Domingo Ribas, Teresa Carrillo Díaz, Marina Blanco Aparicio, Eva Martínez Moragón, David Banas Conejero, M. Guadalupe Sánchez Herrero, Mariana Muñoz, Héctor Cabrerizo, Antonio Valero, Ebymar Arismendi, Irina Bobolea, Gemma López, Celia Pinedo, Francisco Javier González-Barcala, Purificación Pérez-López-Corona, Jacinto Ramos-González, Javier Martín-Puentes, Gregorio Soto-Campos, Francisco Pérez-Grimaldi, Inmaculada Lluch, Juan Luis García-Rivero, Celia Gutierrez-Villegas, Idoia Salinas-Garrido, Cleofé Fernández-Aracil, Luis Puente-Maestu, Walther Iván Girón, Ángela Gómez-Sacristán, Miguel Díaz-Palacios, Ethel Ibáñez, Irene De Lorenzo, Ana Sogo, Daniel Ross-Monserrate, Elena Prina, Eusebi Chiner-Vives, Sandra Vañes, Rocío Díaz-Campos, Ismael García-Moguel, Carmen Montero, María Fernández-Marrube, Tamara Hermida-Valverde, Anaís Enríquez, Nuria Marina-Malanda, Ana Gómez-Larrauri, Antonio García-Dumpiérrez, Rodolfo Castillo-Sainz, Nancy Ortega, Lourdes Almeida, Luis Cabanes, Santiago Quirce, Javier Dominguez-Ortega, David Romero, Irene Hernández, Daniel Laorden, Carolina Cisneros, Antolín López-Viña, Andrea Trisán, Teresa Caruana-Careaga, Ana Gómez-Bastero, Lucía Marín-Barrera

Furmonertinib: First Approval

  • NSCLC
  • AdisInsight Report

Emma D. Deeks

Odevixibat: First Approval

  • Open Access
  • Pruritus
  • AdisInsight Report

Emma D. Deeks

Finerenone: First Approval

James E. Frampton

Anifrolumab: First Approval

Emma D. Deeks

Avalglucosidase alfa: First Approval

Sohita Dhillon

Correction to: Tralokinumab: First Approval

  • Open Access
  • Correction

Sean Duggan

Correction to: Tralokinumab: First Approval

  • Open Access
  • Correction

Sean Duggan

Correction to: Odevixibat: First Approval

  • Open Access
  • Correction

Emma D. Deeks

Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

  • Open Access
  • Nausea
  • Correction

Matt Shirley

Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

José M. Valdivielso, Olga Balafa, Robert Ekart, Charles J. Ferro, Francesca Mallamaci, Patrick B. Mark, Patrick Rossignol, Pantelis Sarafidis, Lucia Del Vecchio, Alberto Ortiz

Sep 21
Issue: 14/2021
Nov 21
Issue: 16/2021

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images